Join a Legacy of Innovation 110 Years and Counting! With over 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for hypertension and thrombotic disorders, under the Groups 2025 Vision to become a Global Pharma Innovator with a Competitive Advantage in Oncology, Daiichi Sankyo research and development is primarily focused on bringing forth novel therap...
Visit
Careersaas to find millions of new and unfilled roles, including thousands of remote and hybrid positions.
